Tissue Processing Systems Market Research Report 2021-2031

The tissue processing systems market was estimated to be US$ 375.86 Mn in 2021 and US$ xx million in 2023. It is expected to reach US$ 660.52 Mn by 2031 and record a CAGR of 5.80% until 2031. Changing consumer preferences and technological advancements will likely remain key tissue processing systems market trends.

Tissue Processing Systems Market Analysis

Increasing prevalence of cancer is expected to drive the tissue processing systems market's growth. Rising prevalence of the cancer is expected to increase the demand for tissue processing systems for diagnosis. As per the World Health Organization (WHO)’s cancer agency, the International Agency for Research on Cancer (IARC), in 2022, there were an estimated 20 million new cancer cases and around 9.7 million deaths.

 Tissue Processing Systems Market Overview

Global tissue processing systems market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. The market growth in this region is expected due to factors such as the increasing cancer prevalence and increasing number of diagnostic laboratories. However, high cost of cancer diagnostics is expected to obstruct the growth of the market to a certain extent during the forecast years.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Get FREE CUSTOMIZATION

Tissue Processing Systems Market: Strategic Insights

• Get Top Key Market Trends of this report.
  This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Free Sample PDF

Tissue Processing Systems Market Drivers and Opportunities

Rising Number of Diagnostic Laboratories to Favor the Market.

There is an increase in number of diagnostic laboratories, owing to rise in chronic conditions. Increase in chronic conditions, such as cancer, diabetes, and heart diseases, leads to the increased demand for diagnostic services. The Centers for Medicare & Medicaid Services regulates all the laboratory tests performed on humans in the US through Clinical Laboratory Improvement Amendments (CLIA). CLIA has approximately 317,545 laboratories registered (Exempt/Non-Exempt) as of March 2024. Moreover, presence of major diagnostic laboratories in the US is likely to favor the market growth. For instance, Quest Diagnostics is a leader in medical diagnostic industry offering diagnostic services in the US. It is the most extensive network in the US, with over 7,400 patient access points, which include phlebotomists in physician offices and over 2,250 of patient service centers.

Emerging Markets in Asia Pacific – An Opportunity in Tissue Processing Systems Market

The emerging markets in the developing countries in the Asia Pacific region are creating better opportunities for significant market players to expand their business. This is a prime reason for market growth in the forecast period. Most of the major players focus on emerging markets, such as India and China, owing to large number of cancer patients and rise in medical tourism in developing countries. Many of the emerging countries are a preferred location for medical tourism.

As per the Globocan 2022: India Factsheet, there were 1,413,316 new cases of cancer and 916,827 cancer deaths in 2022. Also, rising medical tourism in emerging countries and growing prevalence of chronic conditions in the region are likely to provide significant growth opportunities to the players operating in the market during the forecast period.

Tissue Processing Systems Market Report Segmentation Analysis

Key segments that contributed to the tissue processing systems market analysis derivation are services and applications.

• Based on product, the tissue processing systems market is segmented into tissue transfer processors and fluid transfer processors. The fluid transfer processors segment held the largest share of the market, whereas the tissue transfer processors segment is anticipated to register the highest CAGR in the market during the forecast period.
• The market is segmented by volume into small volume processors, medium volume processors, and large volume processors. The small volume segment held the largest share of the market in 2023. However, medium volume segment is anticipated to register the highest CAGR in the market during the forecast period.
• By end-user, the tissue processing systems market has been segmented into hospitals, pharmaceutical companies, research laboratories, and others. The hospitals segment held the largest share of the market, whereas, the pharmaceutical companies segment is estimated to register the highest CAGR in the market during the forecast period.

Tissue Processing Systems Market Share Analysis by Geography

The geographic scope of the tissue processing systems market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America.

North America includes US, Canada and Mexico. The market in North America held a significant share of the global market during the year 2023. The demand for the market in the region is anticipated to witness growth at a significant rate during the forecast period owing to various factors such as rising prevalence of cancer, along with increasing awareness regarding the chronic health condition as well as the presence of supportive associations in the region. There were many organizations that were involved in the investments and creating awareness regarding cancer and its diagnostics.

The Asia Pacific is the fastest-growing market for tissue processing systems in a global scenario owing to the rising aging population, increasing cases of cancer, advancement in technology and increasing government initiatives to offer affordable advanced healthcare, and increasing number of startups, medical device companies in this region. Besides, rising incidence as well as mortality rates of cancer, research activities in the region as well as presence of associations or organizations enhancing the quality of care in cancer also contribute to the market growth.

Tissue Processing Systems Market Regional Insights

The regional trends and factors influencing the Tissue Processing Systems Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Tissue Processing Systems Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Tissue Processing Systems Market Report Scope

Market Players Density: Understanding Its Impact on Business Dynamics

The Tissue Processing Systems Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

Major Companies operating in the Tissue Processing Systems Market are:

1. Agilent Technologies Inc.,
2. Biogenex Laboratories,
3. Sakura Finetek Usa Inc.,
4. Thermo Fisher Scientific Inc.,
5. F. Hoffmann-La Roche AG,
6. Siemens Ag,

Disclaimer: The companies listed above are not ranked in any particular order.

Tissue Processing Systems Market News and Recent Developments

The tissue processing systems market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for tissue processing systems and strategies:

• In August 2023, Sakura Finetek USA launched two new Tissue-Tek Genie branded products that enable CISH testing on the Tissue-Tek Genie Advanced Staining System. (Source: Company Press Release)
• In February 2023, Clarapath, a robotics company, acquired Crosscope. The acquisition combines Clarapath's SectionStar, the first fully automated, all-in-one tissue sectioning and transfer system, with Crosscope's workflow and computational pathology tools, enabling labs to deliver care faster, more cost-effectively, and at higher quality. (Source: Company Press Release)

Tissue Processing Systems Market Report Coverage and Deliverables

The “Tissue Processing Systems Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

• Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Market dynamics such as drivers, restraints, and key opportunities
• Key future trends
• Detailed PEST/Porter’s Five Forces and SWOT analysis
• Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
• Detailed company profiles